FDA OKs morning-after pill retail sale

Over-the-counter sale of Plan B, or the morning-after contraceptive pill was approved by the U.S. Food and Drug Administration Thursday.

In a statement, the agency said it will be available only to women 18 years old or older, and that a prescription would still be required for anyone younger.

Plan B contains the same ingredient used in prescription birth control pills, but a higher dose and the product has a different dosing regimen, the statement said.

When used as directed, it effectively and safely prevents pregnancy, the FDA said.

The drug will be marketed by Duramed, a subsidiary of Barr Pharmaceuticals.

Copyright 2006 by United Press International

Citation: FDA OKs morning-after pill retail sale (2006, August 24) retrieved 18 April 2024 from https://medicalxpress.com/news/2006-08-fda-oks-morning-after-pill-retail.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Risk of death decreases after COVID-19 vaccine but protection wanes after six months, finds study

 shares

Feedback to editors